These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 28622910)

  • 1. The link between morphology and complement in ocular disease.
    Mohlin C; Sandholm K; Ekdahl KN; Nilsson B
    Mol Immunol; 2017 Sep; 89():84-99. PubMed ID: 28622910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of complement system in ocular diseases including uveitis and macular degeneration.
    Jha P; Bora PS; Bora NS
    Mol Immunol; 2007 Sep; 44(16):3901-8. PubMed ID: 17768108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement, innate immunity and ocular disease.
    Sohn JH; Bora PS; Jha P; Tezel TH; Kaplan HJ; Bora NS
    Chem Immunol Allergy; 2007; 92():105-114. PubMed ID: 17264487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The eye as a complement dysregulation hotspot.
    Clark SJ; Bishop PN
    Semin Immunopathol; 2018 Jan; 40(1):65-74. PubMed ID: 28948331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement regulation in the eye: implications for age-related macular degeneration.
    Wilke GA; Apte RS
    J Clin Invest; 2024 May; 134(9):. PubMed ID: 38690727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of complement in ocular pathology.
    Bora NS; Jha P; Bora PS
    Semin Immunopathol; 2008 Apr; 30(2):85-95. PubMed ID: 18299835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doyne lecture 2016: intraocular health and the many faces of inflammation.
    Dick AD
    Eye (Lond); 2017 Jan; 31(1):87-96. PubMed ID: 27636226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells.
    Hinson SR; McKeon A; Fryer JP; Apiwattanakul M; Lennon VA; Pittock SJ
    Arch Neurol; 2009 Sep; 66(9):1164-7. PubMed ID: 19752309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement: an overview for the clinician.
    Varela JC; Tomlinson S
    Hematol Oncol Clin North Am; 2015 Jun; 29(3):409-27. PubMed ID: 26043382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic analysis of the complement pathways in patients with neuromyelitis optica indicates alteration but no activation during remission.
    Veszeli N; Füst G; Csuka D; Trauninger A; Bors L; Rozsa C; Nagy Z; Jobbágy Z; Eizler K; Prohászka Z; Varga L; Illes Z
    Mol Immunol; 2014 Feb; 57(2):200-9. PubMed ID: 24172223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced complement consumption in neuromyelitis optica and Behçet's disease patients.
    Tüzün E; Kürtüncü M; Türkoğlu R; Içöz S; Pehlivan M; Birişik O; Eraksoy M; Akman-Demir G
    J Neuroimmunol; 2011 Apr; 233(1-2):211-5. PubMed ID: 21215465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The complement system and age-related macular degeneration.
    Sivaprasad S; Chong NV
    Eye (Lond); 2006 Aug; 20(8):867-72. PubMed ID: 16410816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inherited complement regulatory protein deficiency predisposes to human disease in acute injury and chronic inflammatory statesthe examples of vascular damage in atypical hemolytic uremic syndrome and debris accumulation in age-related macular degeneration.
    Richards A; Kavanagh D; Atkinson JP
    Adv Immunol; 2007; 96():141-77. PubMed ID: 17981206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A renewed appreciation for ocular immune privilege.
    Niederkorn JY
    Arch Soc Esp Oftalmol; 2005 Aug; 80(8):437-8; 439-40. PubMed ID: 16136394
    [No Abstract]   [Full Text] [Related]  

  • 15. Complement activation and inhibition: a delicate balance.
    Sjöberg AP; Trouw LA; Blom AM
    Trends Immunol; 2009 Feb; 30(2):83-90. PubMed ID: 19144569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low expression of complement inhibitory protein CD59 contributes to humoral autoimmunity against astrocytes.
    Wang Z; Guo W; Liu Y; Gong Y; Ding X; Shi K; Thome R; Zhang GX; Shi FD; Yan Y
    Brain Behav Immun; 2017 Oct; 65():173-182. PubMed ID: 28476558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between the complement system, risk factors and prediction models in age-related macular degeneration.
    Bora NS; Matta B; Lyzogubov VV; Bora PS
    Mol Immunol; 2015 Feb; 63(2):176-83. PubMed ID: 25074023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immune mechanisms in retinal degeneration].
    Karlstetter M; Langmann T
    Klin Monbl Augenheilkd; 2012 Mar; 229(3):221-6. PubMed ID: 22297848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of complement in innate immunity and host defense.
    Trouw LA; Daha MR
    Immunol Lett; 2011 Jul; 138(1):35-7. PubMed ID: 21333684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-related macular degeneration and the complement system.
    Khandhadia S; Cipriani V; Yates JR; Lotery AJ
    Immunobiology; 2012 Feb; 217(2):127-46. PubMed ID: 21868123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.